Eugia SEZ Pvt Ltd gets 7 observations from USFDA for injectable facility

The United States Food and Drug Administration (US FDA) inspected the injectable facility of Eugia SEZ Pvt. Ltd. (a 100% step-down subsidiary of Aurobindo Pharma Ltd.), situated at Polepally Village, Jadcherla Mandal, Mahaboobnagar District, Telangana, from 19th to 29th February 2024.

The inspection closed with 7 observations. The observations are procedural in nature and will be responded to within the stipulated time.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1027.45 as compared to the previous close of Rs. 1028.15. The total number of shares traded during the day was 24855 in over 1206 trades.

The stock hit an intraday high of Rs. 1032.35 and intraday low of 1015.55. The net turnover during the day was Rs. 25422891.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 EugiaSEZ Inspection USFDA 7Observations